Frank P. Zemlan

Affiliations: 
University of Cincinnati, Cincinnati, OH 
Google:
"Frank Zemlan"
Mean distance: 15.61 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schmeichel BE, Zemlan FP, Berridge CW. (2013) A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder. Neuropharmacology. 64: 321-8
Gabbita SP, Srivastava MK, Eslami P, et al. (2012) Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease. Journal of Neuroinflammation. 9: 99
Ma M, Lindsell CJ, Rosenberry CM, et al. (2008) Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury. The American Journal of Emergency Medicine. 26: 763-8
Straiko MM, Coolen LM, Zemlan FP, et al. (2007) The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain. Neuroscience. 144: 223-31
Straiko MM, Gudelsky GA, Coolen LM, et al. (2006) Treatment with trimethyltin promotes the formation of cleaved tau in the rat brain. Journal of Neuroscience Research. 84: 1116-23
Bazarian JJ, Zemlan FP, Mookerjee S, et al. (2006) Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Injury. 20: 759-65
Zemlan FP, Mulchahey JJ, Scharf MB, et al. (2005) The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial. The Journal of Clinical Psychiatry. 66: 384-90
Gabbita SP, Scheff SW, Menard RM, et al. (2005) Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. Journal of Neurotrauma. 22: 83-94
Mulchahey JJ, Goldwater DR, Zemlan FP. (2004) A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin. Life Sciences. 75: 1843-56
Zemlan FP, Mulchahey JJ, Gudelsky GA. (2003) Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: cleaved microtubule-associated protein-tau (C-tau). Neuroscience. 121: 399-409
See more...